315 related articles for article (PubMed ID: 26003503)
1. The incidence and clinical impact of bone metastases in non-small cell lung cancer.
Kuchuk M; Kuchuk I; Sabri E; Hutton B; Clemons M; Wheatley-Price P
Lung Cancer; 2015 Aug; 89(2):197-202. PubMed ID: 26003503
[TBL] [Abstract][Full Text] [Related]
2. Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13.
Katakami N; Kunikane H; Takeda K; Takayama K; Sawa T; Saito H; Harada M; Yokota S; Ando K; Saito Y; Yokota I; Ohashi Y; Eguchi K
J Thorac Oncol; 2014 Feb; 9(2):231-8. PubMed ID: 24419421
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
[TBL] [Abstract][Full Text] [Related]
4. EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?
Hendriks LE; Smit EF; Vosse BA; Mellema WW; Heideman DA; Bootsma GP; Westenend M; Pitz C; de Vries GJ; Houben R; Grünberg K; Bendek M; Speel EJ; Dingemans AM
Lung Cancer; 2014 Apr; 84(1):86-91. PubMed ID: 24529684
[TBL] [Abstract][Full Text] [Related]
5. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study.
Cetin K; Christiansen CF; Jacobsen JB; Nørgaard M; Sørensen HT
Lung Cancer; 2014 Nov; 86(2):247-54. PubMed ID: 25240518
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
[TBL] [Abstract][Full Text] [Related]
7. Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases.
Udagawa H; Niho S; Kirita K; Umemura S; Matsumoto S; Yoh K; Goto K
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1075-1082. PubMed ID: 28220258
[TBL] [Abstract][Full Text] [Related]
8. Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer.
da Silva GT; Bergmann A; Thuler LCS
Support Care Cancer; 2016 Feb; 24(2):731-736. PubMed ID: 26143039
[TBL] [Abstract][Full Text] [Related]
9. Skeletal metastases in non-small cell lung cancer: a retrospective study.
Tsuya A; Kurata T; Tamura K; Fukuoka M
Lung Cancer; 2007 Aug; 57(2):229-32. PubMed ID: 17451841
[TBL] [Abstract][Full Text] [Related]
10. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
11. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
[TBL] [Abstract][Full Text] [Related]
12. Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases.
Sun JM; Ahn JS; Lee S; Kim JA; Lee J; Park YH; Park HC; Ahn MJ; Ahn YC; Park K
Lung Cancer; 2011 Jan; 71(1):89-93. PubMed ID: 20598769
[TBL] [Abstract][Full Text] [Related]
13. Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates.
Langer C; Hirsh V
Lung Cancer; 2010 Jan; 67(1):4-11. PubMed ID: 19939491
[TBL] [Abstract][Full Text] [Related]
14. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
15. Spine-specific skeletal related events and mortality in non-small cell lung cancer patients: a single-institution analysis.
Adogwa O; Rubio DR; Buchowski JM; D'Souza A; Shlykov MA; Jennings JW
J Neurosurg Spine; 2022 Jan; 36(1):125-132. PubMed ID: 33254136
[TBL] [Abstract][Full Text] [Related]
16. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis.
Bae HM; Lee SH; Kim TM; Kim DW; Yang SC; Wu HG; Kim YW; Heo DS
Lung Cancer; 2012 Sep; 77(3):572-7. PubMed ID: 22672969
[TBL] [Abstract][Full Text] [Related]
18. Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients.
Song Q; Shang J; Zhang C; Zhang L; Wu X
J Cancer Res Clin Oncol; 2019 Mar; 145(3):737-746. PubMed ID: 30603904
[TBL] [Abstract][Full Text] [Related]
19. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.
Ceresoli GL; Reni M; Chiesa G; Carretta A; Schipani S; Passoni P; Bolognesi A; Zannini P; Villa E
Cancer; 2002 Aug; 95(3):605-12. PubMed ID: 12209754
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of zoledronic acid and strontium-89 in patients with asymptomatic bone metastases from non-small-cell lung cancer.
Wang Y; Tao H; Yu X; Wang Z; Wang M
Clin Lung Cancer; 2013 May; 14(3):254-60. PubMed ID: 23103352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
